The Global Health Body Issues Warning Over Severe Shortage of Obesity Medications

Under one in 10 patients that would benefit from GLP-1 drugs like Wegovy can access them, caution the global health agency as it issues its inaugural recommendations on the medications.

Considering over a billion individuals worldwide currently living with obesity, it is urging more widespread and fairer access to GLP-1 medication.

According to forecasts, in excess of 2,000,000,000 are projected to be obese by 2030 unless action is taken.

"Our latest guidance affirms that obesity is a chronic disease that can be treated with comprehensive and ongoing support," remarked the agency's head Tedros Adhanom Ghebreyesus.

Significant expense, limited production capacity, and logistical bottlenecks are significant barriers to universal access to the treatments that can help people shift substantial body mass, notes the organization.

GLP-1 Therapy Supply Crisis

Even under the present best projected case, the supply of GLP-1 therapies would only suffice for about 100 million people – under 10% of the global need, as stated by the health organization.

The guideline encourages governments and firms to increase availability, by measures including patent sharing.

Exclusive production rights on a key compound – the primary ingredient of Novo Nordisk's Wegovy – is due to expire in a number of countries in 2026.

How Obesity Jabs Work

These medications imitate a natural hormone to reduce digestion speed, reduce hunger and enhance feelings of fullness so users reduce food intake.

Patients usually begin shedding pounds after several weeks of commencing the weekly injections.

Studies indicates patients may regain a significant portion within a year of stopping the medication, as their typical appetite return.

Being carrying excess weight elevates your chance for developing health problems, including type 2 diabetes, cardiovascular issues, stroke, and specific cancers.

Excess weight impacts individuals in every country and was associated with 3.7 million deaths worldwide in 2024, according to the health agency.